167 related articles for article (PubMed ID: 37649350)
1. Identifying and addressing unmet clinical needs in primary cutaneous B-cell lymphoma: A consensus-based paper from an ad-hoc international panel.
Quaglino P; Pimpinelli N; Zinzani PL; Paulli M; Pileri S; Berti E; Cerroni L; Guitart J; Kim YH; Rupoli S; Santucci M; Simontacchi G; Vermeer M; Hoppe R; Pro B; Swerdlow SH; Barosi G
Hematol Oncol; 2024 Jan; 42(1):e3215. PubMed ID: 37649350
[TBL] [Abstract][Full Text] [Related]
2. Cutaneous B-cell lymphomas: Update on diagnosis, risk-stratification, and management.
Fava P; Roccuzzo G; Alberti-Violetti S; Grandi V; Pileri A; Pimpinelli N; Berti E; Quaglino P
Presse Med; 2022 Mar; 51(1):104109. PubMed ID: 35026390
[TBL] [Abstract][Full Text] [Related]
3. European Organization for Research and Treatment of Cancer and International Society for Cutaneous Lymphoma consensus recommendations for the management of cutaneous B-cell lymphomas.
Senff NJ; Noordijk EM; Kim YH; Bagot M; Berti E; Cerroni L; Dummer R; Duvic M; Hoppe RT; Pimpinelli N; Rosen ST; Vermeer MH; Whittaker S; Willemze R; ;
Blood; 2008 Sep; 112(5):1600-9. PubMed ID: 18567836
[TBL] [Abstract][Full Text] [Related]
4. Primary cutaneous B-cell lymphomas: recent advances in diagnosis and management.
Sokol L; Naghashpour M; Glass LF
Cancer Control; 2012 Jul; 19(3):236-44. PubMed ID: 22710899
[TBL] [Abstract][Full Text] [Related]
5. Update in Diagnosis and Management of Primary Cutaneous B-Cell Lymphomas.
Krenitsky A; Klager S; Hatch L; Sarriera-Lazaro C; Chen PL; Seminario-Vidal L
Am J Clin Dermatol; 2022 Sep; 23(5):689-706. PubMed ID: 35854102
[TBL] [Abstract][Full Text] [Related]
6. [Cutaneous B-cell lymphoma].
Cortés B; Prins C
Rev Med Suisse; 2014 Apr; 10(424):738, 740-3. PubMed ID: 24772806
[TBL] [Abstract][Full Text] [Related]
7. Primary Cutaneous B-Cell Lymphoma: Management and Patterns of Recurrence at the Multimodality Cutaneous Lymphoma Clinic of The Ohio State University.
Haverkos B; Tyler K; Gru AA; Winardi FK; Frederickson J; Hastings J; Elkins C; Zhang X; Xu-Welliver M; Wong HK; Porcu P
Oncologist; 2015 Oct; 20(10):1161-6. PubMed ID: 26306900
[TBL] [Abstract][Full Text] [Related]
8. Unmet clinical needs in the use of zanubrutinib in malignant lymphomas (Waldenström macroglobulinemia, marginal zone lymphoma and mantle cell lymphoma): A consensus-based position paper from an ad hoc expert panel.
Zinzani PL; Mauro FR; Tedeschi A; Varettoni M; Zaja F; Barosi G
Hematol Oncol; 2023 Dec; 41(5):795-808. PubMed ID: 37165730
[TBL] [Abstract][Full Text] [Related]
9. Cutaneous B-Cell Lymphoma.
Goyal A; LeBlanc RE; Carter JB
Hematol Oncol Clin North Am; 2019 Feb; 33(1):149-161. PubMed ID: 30497672
[TBL] [Abstract][Full Text] [Related]
10. Primary cutaneous B-cell lymphomas: a practical approach.
Demierre MF; Kerl H; Willemze R
Hematol Oncol Clin North Am; 2003 Dec; 17(6):1333-50. PubMed ID: 14710888
[TBL] [Abstract][Full Text] [Related]
11. Critical concepts and management recommendations for cutaneous T-cell lymphoma: A consensus-based position paper from the Italian Group of Cutaneous Lymphoma.
Zinzani PL; Quaglino P; Violetti SA; Cantonetti M; Goteri G; Onida F; Paulli M; Rupoli S; Barosi G; Pimpinelli N
Hematol Oncol; 2021 Aug; 39(3):275-283. PubMed ID: 33855728
[TBL] [Abstract][Full Text] [Related]
12. Primary cutaneous B-cell lymphomas. Current concepts. I.
Santucci M; Pimpinelli N
Haematologica; 2004 Nov; 89(11):1360-71. PubMed ID: 15531459
[TBL] [Abstract][Full Text] [Related]
13. Primary cutaneous B-cell lymphoma: review and current concepts.
Pandolfino TL; Siegel RS; Kuzel TM; Rosen ST; Guitart J
J Clin Oncol; 2000 May; 18(10):2152-68. PubMed ID: 10811681
[TBL] [Abstract][Full Text] [Related]
14. Clinical Practice Guidelines for Cutaneous Lymphomas.
Sutton AM; Hurley MY
Mo Med; 2015; 112(4):292-5. PubMed ID: 26455060
[TBL] [Abstract][Full Text] [Related]
15. Differentiation of primary and secondary cutaneous B-cell lymphoma by Southern blot analysis.
Sepp N; Weyer K; Haun M; Zelger B; Thaler J; Faber V; Fritsch P; Grünewald K
Am J Clin Pathol; 1996 Dec; 106(6):749-57. PubMed ID: 8980350
[TBL] [Abstract][Full Text] [Related]
16. [Malignant lymphoma of the skin].
Burg G; Dommann S; Dummer R
Ther Umsch; 1993 Dec; 50(12):828-34. PubMed ID: 8171405
[TBL] [Abstract][Full Text] [Related]
17. Unmet Clinical Needs and Management Recommendations for Blastic Plasmacytoid Dendritic Cell Neoplasm: A Consensus-based Position Paper From an Ad Hoc International Expert Panel.
Pagano L; Zinzani PL; Pileri S; Quaglino P; Cuglievan B; Berti E; Pemmaraju N; Onida F; Willemze R; Orfao A; Barosi G
Hemasphere; 2023 Mar; 7(3):e841. PubMed ID: 36844178
[TBL] [Abstract][Full Text] [Related]
18. [Therapy of primary cutaneous B-cell lymphomas].
Zenahlik P; Fink-Puches R; Kapp KS; Kerl H; Cerroni L
Hautarzt; 2000 Jan; 51(1):19-24. PubMed ID: 10663035
[TBL] [Abstract][Full Text] [Related]
19. Standard and new treatments in cutaneous B-cell lymphomas.
Dreno B
J Cutan Pathol; 2006 Feb; 33 Suppl 1():47-51. PubMed ID: 16412212
[TBL] [Abstract][Full Text] [Related]
20. Unmet Clinical Needs in the Management of Idiopathic Multicentric Castleman Disease: A Consensus-based Position Paper From an ad hoc Expert Panel.
Zinzani PL; Paulli M; Arcaini L; Della Torre E; Ferrero S; Figuera A; Frigeri F; Martelli M; Sabattini E; Scarpa R; Barosi G
Hemasphere; 2023 Jun; 7(6):e891. PubMed ID: 37234822
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
